X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (18) 18
humans (16) 16
index medicus (13) 13
aged (12) 12
chemotherapy (12) 12
male (12) 12
female (11) 11
respiratory system (11) 11
cancer (10) 10
lung cancer, non-small cell (9) 9
middle aged (9) 9
analysis (8) 8
lung neoplasms - pathology (8) 8
adult (7) 7
lung neoplasms - drug therapy (7) 7
aged, 80 and over (6) 6
lung cancer (6) 6
medicine & public health (6) 6
research (6) 6
carcinoma, non-small-cell lung - drug therapy (5) 5
france (5) 5
life sciences (5) 5
lung neoplasms - mortality (5) 5
neoplasm staging (5) 5
non-small cell lung cancer (5) 5
oncology, experimental (5) 5
prognosis (5) 5
prospective studies (5) 5
targeted cancer therapy (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomedicine, general (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
care and treatment (4) 4
concrete (4) 4
creep (4) 4
hematology, oncology and palliative medicine (4) 4
mutation (4) 4
open-label (4) 4
pulmonary/respiratory (4) 4
tyrosine (4) 4
[sdv]life sciences [q-bio] (3) 3
adenocarcinoma (3) 3
age factors (3) 3
azd9291 (3) 3
bronchoscopy (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
critical care medicine (3) 3
crizotinib (3) 3
epidermal growth factor (3) 3
france - epidemiology (3) 3
lung neoplasms - genetics (3) 3
management (3) 3
medical research (3) 3
medicine, experimental (3) 3
metastasis (3) 3
mortality (3) 3
resistance (3) 3
risk factors (3) 3
small cell lung carcinoma - pathology (3) 3
survival (3) 3
treatment outcome (3) 3
[ spi.mat ] engineering sciences [physics]/materials (2) 2
aged patients (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
beton (2) 2
c-s-h (2) 2
carcinoma, non-small-cell lung - epidemiology (2) 2
carcinoma, squamous cell - pathology (2) 2
cement (2) 2
ceritinib (2) 2
construction & building technology (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
disease progression (2) 2
early access program (2) 2
egfr (2) 2
elderly (2) 2
elderly patients (2) 2
engineering sciences (2) 2
epidemiology (2) 2
erlotinib (2) 2
follow-up studies (2) 2
gemcitabine (2) 2
impact (2) 2
induction chemotherapy (2) 2
inhibitors (2) 2
logistic models (2) 2
lung adenocarcinoma (2) 2
lung cancer, small cell (2) 2
lung neoplasms - epidemiology (2) 2
lymphomas (2) 2
materials (2) 2
materials science, multidisciplinary (2) 2
mechanics (2) 2
mechanisms (2) 2
medical prognosis (2) 2
multicenter (2) 2
multivariate analysis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Targeted Oncology, ISSN 1776-2596, 8/2018, Volume 13, Issue 4, pp. 501 - 507
The prognosis of patients with non-small cell lung cancer (NSCLC) who develop leptomeningeal metastasis (LM) is poor.To assess the clinical efficacy of... 
Biomedicine, general | Medicine & Public Health | Oncology | ONCOLOGY | TKIS | RESISTANCE | CARCINOMATOSIS | MUTANT NSCLC | MUTATIONS | AZD9291 | Epidermal growth factor | Metastasis | Mutation | Targeted cancer therapy | Medical prognosis | Lung cancer
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2012, Volume 12, Issue 1, pp. 301 - 301
Journal Article
Targeted Oncology, ISSN 1776-2596, 2019, Volume 14, Issue 3, pp. 307 - 314
Background The resistance mutation T790M is reported in 50-60% of patients pretreated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors... 
MANAGEMENT | NSCLC | VINORELBINE | ONCOLOGY | PHASE-III | RESISTANCE | MECHANISMS | ELDERLY-PATIENTS | AZD9291 | Tyrosine | Medical research | Epidermal growth factor | Analysis | Medicine, Experimental | Lung cancer, Small cell | Metastasis | Lung cancer, Non-small cell
Journal Article
TARGETED ONCOLOGY, ISSN 1776-2596, 12/2017, Volume 12, Issue 6, pp. 841 - 842
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11523-017-0534-1 
ONCOLOGY | Lung cancer, Non-small cell
Journal Article
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 9, pp. 8253 - 8262
To assess efficacy and tolerance of EGFR tyrosine-kinase inhibitors (TKIs) for advanced EGFR-mutated non-small cell lung cancer (NSCLC) in octogenarians.... 
Targeted therapies | Gerotarget | Tyrosine-kinase inhibitors | Elderly | Egfr | Non-small cell lung cancer | Life Sciences | Chemical Sciences | Cancer
Journal Article
Lung Cancer, ISSN 0169-5002, 07/2018, Volume 121, pp. 25 - 29
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2019, Volume 71, Issue 12, pp. 2100 - 2111
Objective Immune checkpoint inhibitors (ICIs) for cancer therapy frequently induce immune‐related adverse effects (IRAEs). Therefore, most patients with... 
Life Sciences
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.